TREM2 and Alzheimer disease: A proactive role of brain immune cells, microglia, in the pathogenesis of Alzheimer’s disease (AD) gained recognition after the discovery of AD-associated variants in the triggering receptor expressed on myeloid cell 2 (TREM2) gene that is only expressed on immune cells of myeloid origin.